TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Lynx1 Capital Management Lp Buys 80,069 Shares of Stock
TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report) major shareholder Lynx1 Capital Management Lp bought 80,069 shares of TScan Therapeutics stock in a transaction on Friday, December 19th. The shares were bought at an average cost of $0.90 per share, with a total value of $72,062.10. Following the acquisition, the insider directly owned 7,937,416 shares […]
24 Dec 11:52 · The Markets Daily